Mesenchymal stem cell therapy for cutaneous radiation syndrome

Area of Science:

• Regenerative medicine
• Tissue engineering
• Radiation oncology

Background:

• Radiation injuries pose significant challenges in wound management.
• Current treatments often involve complex reconstructive surgery with potential morbidity.

Purpose of the Study:

• To evaluate the efficacy of human mesenchymal stem cells (hMSCs) and adipose-derived stem cells (ADSCs) combined with basic fibroblast growth factor (bFGF) and artificial dermis for treating radiation-damaged skin.
• To assess the potential of these regenerative modalities in improving wound healing and reducing complications.

Main Methods:

• Application of hMSCs/ADSCs and bFGF on an artificial dermal template over excised irradiated skin defects in preclinical models and patients.
• In vitro assessment of hMSC proliferation post-irradiation.
• In vivo evaluation of stem cell survival and tissue regeneration in irradiated rats.
• Clinical application in patients with complex underlying diseases requiring reconstructive surgery.

Main Results:

• hMSCs demonstrated robust proliferation even after 20 Gy irradiation in vitro.
• Sustained survival of mesenchymal stem cells in bone marrow after 4 Gy whole-body irradiation in rats.
• Artificial dermis with cells and bFGF significantly improved fat angiogenesis, dermal reconstitution, and epidermal recovery in irradiated tissues.
• Successful reconstruction with perforator flaps and artificial dermal templates in patients, leading to uneventful recovery with minimal morbidity.

Conclusions:

• Regenerative strategies utilizing stem cells, growth factors, and artificial dermis show promise for treating radiation-induced wounds.
• These methods enhance angiogenesis, promote tissue repair, and offer a viable alternative to traditional reconstructive surgery.
• Understanding underlying conditions and employing rational reconstructive procedures are crucial for successful outcomes in complex irradiated wound healing.